Biocartis Group NV

Biocartis Group Nv. Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
  • TickerA14R82
  • ISINBE0974281132
  • ExchangeEuronext Brussels
  • SectorHealth Care Equipment & Services
  • CountryBelgium

Analysts

Jason Kalamboussis ...
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs

Morning Note: AGS BB, BCART BB

Ageas: Miss on CASER, reinforces likelihood of 2020 SBB Biocartis: CFO leaves for personal reasons

Guy Sips ...
  • Lenny Van Steenhuyse
  • Marcel Achterberg
  • Sandra Cauwenberghs
  • Wim Hoste

Morning Note: ASML NA, BALTA BB, BCART BB, BOTHE BB, FFARM NA

ASML: 4Q19 beats, Bullish view on FY20, 1Q20 misses Balta: Sales-and-lease back operation to repay term loan Biocartis: Expanded collaboration with AZ Bone Therapeutics: 2020 outlook – runway tightens. Cash till 3Q20 ForFarmers: Fird flu spreading in CE Europe

Jason Kalamboussis ...
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs

Morning Note: AGS BB, BCART BB

Ageas: Miss on CASER, reinforces likelihood of 2020 SBB Biocartis: CFO leaves for personal reasons

Guy Sips ...
  • Lenny Van Steenhuyse
  • Marcel Achterberg
  • Sandra Cauwenberghs
  • Wim Hoste

Morning Note: ASML NA, BALTA BB, BCART BB, BOTHE BB, FFARM NA

ASML: 4Q19 beats, Bullish view on FY20, 1Q20 misses Balta: Sales-and-lease back operation to repay term loan Biocartis: Expanded collaboration with AZ Bone Therapeutics: 2020 outlook – runway tightens. Cash till 3Q20 ForFarmers: Fird flu spreading in CE Europe

Cedric Duinslaeger ...
  • Guy Sips
  • Jason Kalamboussis
  • Joachim Vansanten
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs
  • Thomas Couvreur

Morning Note: ABN NA, AGFB BB, ARGX BB, BCART BB, EURN BB, ENX FP

ABN Amro: New CEO, but it will take time to address issues Agfa: Pascal Juery (ex Rhodia/Solvay) new CEO Argenx: Update on the strategic outlook for the 2021 vision Biocartis: FY19 guidance achieved Euronav: Guidance on return to shareholders Euronext: December volumes within expectations

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior